Nitazoxanide has been shown to have a clinical efficacy against severe acute respiratory syndrome coronavirus 2; ivermectin has also demonstrated a remarkable experimental efficacy with a potential to be used for Coronavirus disease 2019.
Nitazoxanide has been shown to have a clinical efficacy against severe acute respiratory
syndrome coronavirus; ivermectin has also demonstrated a remarkable experimental efficacy
with a potential to be used for Coronavirus disease 2019. Some studies demonstrated the
efficacy of combined regimen of nitazoxanide and azithromycin or ivermectin and chloroquine.
Drug: Nitazoxanide
Nitazoxanide
Other Name: Parazoxanide, Nanazoxid
Inclusion Criteria:
- Patients with COVID-19 infection
Exclusion Criteria:
- Allergy or contraindication to the drugs.
Tanta University, Assiut University
Tanta, Egypt
Sherief Abd-Elsalam
Tanta, Egypt
Sherief Abd-Elsalam, ass. prof.
00201147773440
sheriefabdelsalam@yahoo.com
sherief Abd-Elsalam, Ass. Prof., Principal Investigator
ass. Prof. Tropical Medicine